← Insider buys
UTHR

United Therapeutics Corporation · Healthcare

EVP and General Counsel Paul A Mahon sold $1.3M of United Therapeutics Corporation

Sold$1,294,903
$215.82Price
6,000Shares
−14%Stake

What UTHR did after the filing

Filed May 4Copier in May 5
The stock from Fri, May 5 open, $217.48
+2.7%
S&P 500, same days
+7.3%

Measured over 30 trading days, to the Jun 20 close.

Traded Thu, May 4. Filed Thu, May 4, 4:30 PM ET, after the close. Returns use the May 5 open and the Jun 20 close. Not investment advice.